PI
CDMO

Putnam Investments’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Putnam Investments’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-136,900
Closed -$561K – 990
2018
Q4 		$561K Buy
+136,900
New +$714K ﹤0.01% 808

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Putnam Investments's CDMO Position: Q1 2019 in Review

Putnam Investments sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2019, closing a stake of 136,900 shares — an estimated $561K sold.

Putnam Investments first reported a position in CDMO in Q4 2018 and held it in 1 quarter. The position peaked at $561K in Q4 2018. 97 funds tracked by Wall St. Rank hold CDMO as of Q1 2019.

  • Putnam Investments reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Putnam Investments sold 136,900 Avid Bioservices, Inc. Common Stock shares in Q1 2019, an estimated $561K.
  • Putnam Investments first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2018 and held it in 1 quarter.
  • Putnam Investments's Avid Bioservices, Inc. Common Stock position peaked at $561K in Q4 2018.
  • 97 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2019.

Based on Putnam Investments's 13F filing for Q1 2019, filed 15 May 2019.